# Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABG

> **NCT06730945** · PHASE4 · WITHDRAWN · sponsor: **Ruijin Hospital**

## Conditions studied

- Coronary Artery Bypass Graft Surgery (CABG)
- Radial Artery Grafts
- Graft Failure

## Interventions

- **DRUG:** Oral isosorbide mononitrate 4+ amlodipine

## Key facts

- **NCT ID:** NCT06730945
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06
- **Primary completion:** 2028-12
- **Final completion:** 2030-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Modify the trial design and construct a new larger trial.
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06730945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06730945, "Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABG". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06730945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*